Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ICU MedicalSTU:IC7 80 EV-to-FCF is 38.54 as of Aug. 17, 2026, which is 0% below its 10-year median of 38.55. GuruFocus rates STU:IC7 with a GF Score™ of 80/100 and a GF Value™ of €105.79 (Significantly Overvalued). The stock has 8 warning signs investors should review. Among 406 Medical Devices & Instruments companies, ICU Medical ranks worse than 67.73% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, ICU Medical's Enterprise Value is €4,809 Mil.
ICU Medical's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2026 was €125 Mil. Therefore, ICU Medical's EV-to-FCF for today is 38.54.
The historical rank and industry rank for ICU Medical's EV-to-FCF or its related term are showing as below:
STU:IC7'
s EV-to-FCF Range Over the Past 10 Years
Min: -5292.64 Med: 38.55 Max: 3918.94
Current: 38.29
During the past 13 years, the highest EV-to-FCF of ICU Medical was 3918.94. The lowest was -5292.64. And the median was 38.55.
STU:IC7's EV-to-FCF is ranked worse than 67.73% of 406
companies
in the Medical Devices & Instruments industry
Industry Median: 25.2
vs STU:IC7: 38.29
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
ICU Medical's PE Ratio (TTM) for today is calculated as:
ICU Medical's share price for today is €158.00.
ICU Medical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €1.032.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
ICU Medical EV-to-FCF Related Terms
ICU Medical EV-to-FCF Historical Data
* Premium members only.
The historical data trend for ICU Medical's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, ICU Medical's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ICU Medical EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, ICU Medical's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where ICU Medical's EV-to-FCF falls into.
ICU Medical's current Enterprise Value is €4,809 Mil.
ICU Medical's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €125 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ICU Medical (STU:IC7) has a EV-to-FCF of 38.54 as of Aug. 17, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on ICU Medical and its competitors. This is near median its historical median of 38.55. According to the industry distribution chart, ICU Medical ranks #275 out of 406 companies in the Medical Devices & Instruments industry, placing it in the top 67.7%.
Is ICU Medical's EV-to-FCF too high?
ICU Medical's current EV-to-FCF of 38.54 is near median its 10-year median of 38.55. The Medical Devices & Instruments industry median EV-to-FCF is 25.20. ICU Medical's value of 38.54 is 52.9% above this industry median. Based on the distribution chart, ICU Medical ranks #275 out of 406 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, ICU Medical has a GF Score™ of 80/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does ICU Medical's EV-to-FCF compare to NVST and MMSI?
According to the Medical Devices & Instruments industry distribution chart, ICU Medical ranks #275 out of 406 companies for EV-to-FCF. This places ICU Medical in the lower half of its industry. The industry median EV-to-FCF is 25.20. ICU Medical's value of 38.54 is 52.9% above this benchmark. While the company's 10-year median is 38.55 vs. the industry median of 25.20, ICU Medical has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 25.20, based on 406 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. ICU Medical's current EV-to-FCF of 38.54 is 52.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on ICU Medical and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 25.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ICU Medical's current EV-to-FCF is 38.54, which is near median its own 10-year median of 38.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ICU Medical stock overvalued right now?
Based on GuruFocus' analysis, ICU Medical (STU:IC7) is currently considered Significantly Overvalued. The stock's GF Value™ is €105.79, compared to a current price of €158.00 — trading 49.4% above its estimated fair value. The current EV-to-FCF is 38.54, which is near median its 10-year median of 38.55 and 52.9% above the Medical Devices & Instruments industry median of 25.20. ICU Medical's overall GF Score™ is 80/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For ICU Medical (STU:IC7), the current EV-to-FCF is 38.54 as of Aug. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is ICU Medical (STU:IC7) Overvalued in 2026?
Based on GuruFocus' analysis, ICU Medical stock appears to be overvalued.
The current stock price of €158.00 is trading 49.4% above its estimated GF Value™ of €105.79.
GuruFocus considers ICU Medical to be Significantly Overvalued.
Key valuation signals for STU:IC7:
EV-to-FCF: 38.54 (near median its 10-year median of 38.55)
GF Value™: €105.79 vs. price of €158.00 (49.4% above fair value)
Industry Position: 52.9% above the Medical Devices & Instruments median (#275 of 406)
No single metric tells the full story. See the STU:IC7 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (50% of consolidated revenue), infusion systems (30%), and vital care (20%). The combined entity remains primarily US-focused, generating over 60% of its sales domestically.
80GF Score
Get the complete analysis for STU:IC7
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:IC7 has been successfully added to your 
